Relative Potency of Formoterol Novolizer® 12 µg Compared to Formoterol Aerolizer® 12 µg
Clinical trial NCT01256086 · COMPLETED
Trial details
- NCT number
- NCT01256086
- Sponsor
- MEDA Pharma GmbH & Co. KG
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2011-07-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.